CoChat
Sign Up
Cited by 20

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Advances in 3D Culture Models to Study Exosomes in Triple-Negative Breast Cancer

Yousafzai, Neelum Aziz, El Khalki, Lamyae, Wang, Wei, Szpendyk, Justin, Sossey-Alaoui, Khalid·2024·Cancers
DOI 10.3390/cancers16050883PMC PMC10931050
Open this paper in CoChat — free account

Abstract

Breast cancer, a leading cause of cancer-related deaths globally, exhibits distinct subtypes with varying pathological, genetic, and clinical characteristics. Despite advancements in breast cancer treatments, its histological and molecular heterogeneity pose a significant clinical challenge. Triple-negative breast cancer (TNBC), a highly aggressive subtype lacking targeted therapeutics, adds to the complexity of breast cancer treatment. Recent years have witnessed the development of advanced 3D culture technologies, such as organoids and spheroids, providing more representative models of healthy human tissue and various malignancies. These structures, resembling organs in structure and function, are generated from stem cells or organ-specific progenitor cells via self-organizing processes. Notably, 3D culture systems bridge the gap between 2D cultures and in vivo studies, offering a more accurate representation of in vivo tumors’ characteristics. Exosomes, small nano-sized molecules secreted by breast cancer and stromal/cancer-associated fibroblast cells, have garnered significant attention. They play a crucial role in cell-to-cell communication, influencing tumor progression, invasion, and metastasis. The 3D culture environment enhances exosome efficiency compared to traditional 2D cultures, impacting the transfer of specific cargoes and therapeutic effects. Furthermore, 3D exosomes have shown promise in improving therapeutic outcomes, acting as potential vehicles for cancer treatment administration. Studies have demonstrated their role in pro-angiogenesis and their innate therapeutic potential in mimicking cellular therapies without side effects. The 3D exosome model holds potential for addressing challenges associated with drug resistance, offering insights into the mechanisms underlying multidrug resistance and serving as a platform for drug screening. This review seeks to emphasize the crucial role of 3D culture systems in studying breast cancer, especially in understanding the involvement of exosomes in cancer pathology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cancers16050883

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Summary of 2D vs. 3D cultures derived from breast cancer cell lines and tumors: The efficiency of production of exosomes and extracellular vesicle (EVs) are significantly higher in the 3D culture models compared to the 2D culture models. Exosomes contain integrins and other cellular proteins, lipids, nucleic acids, as well as miRNAs, which they transfer into the extracellular microenvironment. Exosomes and other extracellular vesicle cargo induce immune system suppressive pathways due to interaction with extracellular matrix to promote epithelial-to-mesenchymal transition (EMT), breast cancer tumorigenesis, invasion, and metastasis.
Figure 1 Summary of 2D vs. 3D cultures derived from breast cancer cell lines and tumors: The efficiency of production of exosomes and extracellular vesicle (EVs) are significantly higher in the 3D culture models compared to the 2D culture models. Exosomes contain integrins and other cellular proteins, lipids, nucleic acids, as well as miRNAs, which they transfer into the extracellular microenvironment. Exosomes and other extracellular vesicle cargo induce immune system suppressive pathways due to interaction with extracellular matrix to promote epithelial-to-mesenchymal transition (EMT), breast cancer tumorigenesis, invasion, and metastasis.CC BY · PubMed Central
Figure 2 Role of tumor-derived exosomes in immune suppression and cancer progression. Schematic representation of immune regulation system via exosomes; structure of tumor derived exosomes which carry several components, nucleic acids, lipid bilayers and proteins including tetraspanin family, adhesion proteins, antigen binding proteins, etc., are associated with immune cells regulation. The exosomes cargo CD63 and CD29 used as “exosome markers” in cancer progression.
Figure 2 Role of tumor-derived exosomes in immune suppression and cancer progression. Schematic representation of immune regulation system via exosomes; structure of tumor derived exosomes which carry several components, nucleic acids, lipid bilayers and proteins including tetraspanin family, adhesion proteins, antigen binding proteins, etc., are associated with immune cells regulation. The exosomes cargo CD63 and CD29 used as “exosome markers” in cancer progression.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 156

  1. Elenbaas, 2001, Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells, Genes Dev., 15, 50, 10.1101/gad.828901 · DOI · Paper page
  2. Wang, 2015, Involvement of Wnt/β-catenin signaling in the mesenchymal stem cells promote metastatic growth and chemoresistance of cholangiocarcinoma, Oncotarget, 6, 42276, 10.18632/oncotarget.5514 · DOI
  3. Dai, 2019, The prognostic impact of age in different molecular subtypes of breast cancer: A population-based study, PeerJ, 7, e7252, 10.7717/peerj.7252 · DOI
  4. Zardavas, 2013, Emerging targeted agents in metastatic breast cancer, Nat. Rev. Clin. Oncol., 10, 191, 10.1038/nrclinonc.2013.29 · DOI
  5. Medina, M.A., Oza, G., Sharma, A., Arriaga, L.G., Hernández Hernández, J.M., Rotello, V.M., and Ramirez, J.T. (2020). Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies. Int. J. Environ. Res. Public Health, 17. · DOI
  6. Russo, 2016, Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer, Cancer Discov., 6, 147, 10.1158/2159-8290.CD-15-1283 · DOI
  7. Eglen, 2015, Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?, Assay Drug Dev. Technol., 13, 262, 10.1089/adt.2015.647 · DOI
  8. Lancaster, 2014, Organogenesis in a dish: Modeling development and disease using organoid technologies, Science, 345, 1247125, 10.1126/science.1247125 · DOI · Paper page
  9. Sato, 2011, Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium, Gastroenterology, 141, 1762, 10.1053/j.gastro.2011.07.050 · DOI · Paper page
  10. Haraszti, 2018, Exosomes Produced from 3D Cultures of MSCs by Tangential Flow Filtration Show Higher Yield and Improved Activity, Mol. Ther., 26, 2838, 10.1016/j.ymthe.2018.09.015 · DOI · Paper page
  11. Yang, 2020, Three-dimensional culture of oral progenitor cells: Effects on small extracellular vesicles production and proliferative function, J. Oral Pathol. Med., 49, 342, 10.1111/jop.12981 · DOI
  12. Thippabhotla, 2019, 3D cell culture stimulates the secretion of in vivo like extracellular vesicles, Sci. Rep., 9, 13012, 10.1038/s41598-019-49671-3 · DOI
  13. Mueller, 2004, Friends or foes—Bipolar effects of the tumour stroma in cancer, Nat. Rev. Cancer, 4, 839, 10.1038/nrc1477 · DOI
  14. Crawford, 2010, Effect of increased extracellular ca on microvesicle production and tumor spheroid formation, Cancer Microenviron., 4, 93, 10.1007/s12307-010-0049-0 · DOI
  15. Kamerkar, 2017, Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer, Nature, 546, 498, 10.1038/nature22341 · DOI · Paper page
  16. Saha, 2016, MicroRNA Cargo of Extracellular Vesicles from Alcohol-exposed Monocytes Signals Naive Monocytes to Differentiate into M2 Macrophages, J. Biol. Chem., 291, 149, 10.1074/jbc.M115.694133 · DOI · Paper page
  17. Didiot, 2016, Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing, Mol. Ther., 24, 1836, 10.1038/mt.2016.126 · DOI · Paper page
  18. Phan, 2018, Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy, J. Extracell. Vesicles, 7, 1522236, 10.1080/20013078.2018.1522236 · DOI
  19. Yan, 2020, Exosomes produced from 3D cultures of umbilical cord mesenchymal stem cells in a hollow-fiber bioreactor show improved osteochondral regeneration activity, Cell Biol. Toxicol., 36, 165, 10.1007/s10565-019-09504-5 · DOI
  20. Mao, 2019, The Exosome And Breast Cancer Cell Plasticity, Onco Targets Ther., 12, 9817, 10.2147/OTT.S214133 · DOI
  21. Berman, 2013, Incidence and patterns of distant metastases for patients with early-stage breast cancer after breast conservation treatment, Clin. Breast Cancer, 13, 88, 10.1016/j.clbc.2012.11.001 · DOI
  22. Zardawi, 2009, Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer, Histol. Histopathol., 24, 385
  23. Sun, 2019, Application potential of stem/progenitor cell-derived extracellular vesicles in renal diseases, Stem Cell Res. Ther., 10, 8, 10.1186/s13287-018-1097-5 · DOI
  24. Lu, 2019, Bone Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Recovery Following Spinal Cord Injury via Improvement of the Integrity of the Blood-Spinal Cord Barrier, Front. Neurosci., 13, 209, 10.3389/fnins.2019.00209 · DOI
  25. Wu, 2019, miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis, Biomaterials, 206, 87, 10.1016/j.biomaterials.2019.03.022 · DOI
  26. Lou, 2017, Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases, Exp. Mol. Med., 49, e346, 10.1038/emm.2017.63 · DOI
  27. Li, 2015, Bridging the Gap: From 2D Cell Culture to 3D Microengineered Extracellular Matrices, Adv. Healthc. Mater., 4, 2780, 10.1002/adhm.201500427 · DOI
  28. Marino, 2019, 2D and 3D In Vitro Co-Culture for Cancer and Bone Cell Interaction Studies, Methods Mol. Biol., 1914, 71, 10.1007/978-1-4939-8997-3_5 · DOI
  29. Lou, 2017, Lost in translation: Applying 2D intercellular communication via tunneling nanotubes in cell culture to physiologically relevant 3D microenvironments, FEBS J., 284, 699, 10.1111/febs.13946 · DOI
  30. Li, 2006, Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays, Cancer Res., 66, 1990, 10.1158/0008-5472.CAN-05-2593 · DOI
  31. Shao, 2018, New Technologies for Analysis of Extracellular Vesicles, Chem. Rev., 118, 1917, 10.1021/acs.chemrev.7b00534 · DOI
  32. Hsieh, C.H., Chen, Y.D., Huang, S.F., Wang, H.M., and Wu, M.H. (2015). The effect of primary cancer cell culture models on the results of drug chemosensitivity assays: The application of perfusion microbioreactor system as cell culture vessel. Biomed. Res. Int., 2015. · DOI
  33. Kim, 2018, Three-Dimensional Spheroid Culture Increases Exosome Secretion from Mesenchymal Stem Cells, Tissue Eng. Regen. Med., 15, 427, 10.1007/s13770-018-0139-5 · DOI
  34. Jia, 2017, Exosome: Emerging biomarker in breast cancer, Oncotarget, 8, 41717, 10.18632/oncotarget.16684 · DOI
  35. Minciacchi, 2015, Extracellular vesicles in cancer: Exosomes, microvesicles and the emerging role of large oncosomes, Semin. Cell Dev. Biol., 40, 41, 10.1016/j.semcdb.2015.02.010 · DOI
  36. Umezu, 2013, Leukemia cell to endothelial cell communication via exosomal miRNAs, Oncogene, 32, 2747, 10.1038/onc.2012.295 · DOI
  37. Savina, 2003, Exosome release is regulated by a calcium-dependent mechanism in K562 cells, J. Biol. Chem., 278, 20083, 10.1074/jbc.M301642200 · DOI
  38. Fader, 2008, Induction of autophagy promotes fusion of multivesicular bodies with autophagic vacuoles in k562 cells, Traffic, 9, 230, 10.1111/j.1600-0854.2007.00677.x · DOI
  39. Savina, 2005, Rab11 promotes docking and fusion of multivesicular bodies in a calcium-dependent manner, Traffic, 6, 131, 10.1111/j.1600-0854.2004.00257.x · DOI
  40. Salomon, C., Ryan, J., Sobrevia, L., Kobayashi, M., Ashman, K., Mitchell, M., and Rice, G.E. (2013). Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS ONE, 8. · DOI
  41. Smith, 1946, Cystic Organoid Teratoma: (Report of a Case), Can. Med. Assoc. J., 55, 151
  42. Dutta, 2017, Disease Modeling in Stem Cell-Derived 3D Organoid Systems, Trends Mol. Med., 23, 393, 10.1016/j.molmed.2017.02.007 · DOI · Paper page
  43. Krishnamurthy, 2013, Orosphere assay: A method for propagation of head and neck cancer stem cells, Head Neck, 35, 1015, 10.1002/hed.23076 · DOI
  44. Eguchi, T., Sogawa, C., Okusha, Y., Uchibe, K., Iinuma, R., Ono, K., Nakano, K., Murakami, J., Itoh, M., and Arai, K. (2018). Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment. PLoS ONE, 13. · DOI
  45. Bijonowski, 2019, Size-Dependent Cortical Compaction Induces Metabolic Adaptation in Mesenchymal Stem Cell Aggregates, Tissue Eng. Part A, 25, 575, 10.1089/ten.tea.2018.0155 · DOI
  46. Yuan, 2022, Engineering extracellular vesicles by three-dimensional dynamic culture of human mesenchymal stem cells, J. Extracell. Vesicles, 11, e12235, 10.1002/jev2.12235 · DOI
  47. Park, 2019, Up-regulated fibronectin in 3D culture facilitates spreading of triple negative breast cancer cells on 2D through integrin β-5 and Src, Sci. Rep., 9, 19950, 10.1038/s41598-019-56276-3 · DOI
  48. Rocha, 2019, 3D Cellular Architecture Affects MicroRNA and Protein Cargo of Extracellular Vesicles, Adv. Sci., 6, 1800948, 10.1002/advs.201800948 · DOI
  49. Brown, 2011, CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression, J. Clin. Investig., 121, 1064, 10.1172/JCI44540 · DOI
  50. Horiguchi, 2012, TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP, Oncogene, 31, 3190, 10.1038/onc.2011.493 · DOI
  51. Abdollahi, 2021, Extracellular vesicles from organoids and 3D culture systems, Biotechnol. Bioeng., 118, 1029, 10.1002/bit.27606 · DOI
  52. Xu, 2020, Exosome-based immunotherapy: A promising approach for cancer treatment, Mol. Cancer, 19, 160, 10.1186/s12943-020-01278-3 · DOI · Paper page
  53. Thompson, R.E., Bouma, G.J., and Hollinshead, F.K. (2022). The Roles of Extracellular Vesicles and Organoid Models in Female Reproductive Physiology. Int. J. Mol. Sci., 23. · DOI
  54. Bhattacharya, S., Calar, K., Evans, C., Petrasko, M., and de la Puente, P. (2020). Bioengineering the Oxygen-Deprived Tumor Microenvironment Within a Three-Dimensional Platform for Studying Tumor-Immune Interactions. Front. Bioeng. Biotechnol., 8. · DOI
  55. Gernapudi, 2015, Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer, Breast Cancer Res. Treat., 150, 685, 10.1007/s10549-015-3326-2 · DOI
  56. Yang, 2018, Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth, Cell Res., 28, 862, 10.1038/s41422-018-0060-4 · DOI
  57. Ohno, 2013, Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells, Mol. Ther., 21, 185, 10.1038/mt.2012.180 · DOI · Paper page
  58. Dutta, S., Warshall, C., Bandyopadhyay, C., Dutta, D., and Chandran, B. (2014). Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells. PLoS ONE, 9. · DOI
  59. Tu, J., Luo, X., Liu, H., Zhang, J., and He, M. (2021). Cancer spheroids derived exosomes reveal more molecular features relevant to progressed cancer. Biochem. Biophys. Rep., 26. · DOI
  60. Chen, 2021, Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28, Theranostics, 11, 3932, 10.7150/thno.53412 · DOI
  61. Liu, 2022, Exosomal circCARM1 from spheroids reprograms cell metabolism by regulating PFKFB2 in breast cancer, Oncogene, 41, 2012, 10.1038/s41388-021-02061-4 · DOI
  62. Pullan, 2022, Modified Bovine Milk Exosomes for Doxorubicin Delivery to Triple-Negative Breast Cancer Cells, ACS Appl. Bio Mater., 5, 2163, 10.1021/acsabm.2c00015 · DOI
  63. Cui, 2022, Brain organoid-on-chip system to study the effects of breast cancer derived exosomes on the neurodevelopment of brain, Cell Regen., 11, 7, 10.1186/s13619-021-00102-7 · DOI
  64. Lucotti, 2020, Recent Advances in Experimental Models of Breast Cancer Exosome Secretion, Characterization and Function, J. Mammary Gland. Biol. Neoplasia, 25, 305, 10.1007/s10911-020-09473-0 · DOI
  65. Shibuya, 2020, MicroRNA-93 targets WASF3 and functions as a metastasis suppressor in breast cancer, Cancer Sci., 111, 2093, 10.1111/cas.14423 · DOI
  66. Casson, 2018, Mesenchymal stem cell-derived extracellular vesicles may promote breast cancer cell dormancy, J. Tissue Eng., 9, 2041731418810093, 10.1177/2041731418810093 · DOI
  67. Gebeyehu, 2021, Role of Exosomes for Delivery of Chemotherapeutic Drugs, Crit. Rev. Ther. Drug Carr. Syst., 38, 53, 10.1615/CritRevTherDrugCarrierSyst.2021036301 · DOI
  68. Kalluri, 2020, The biology, function, and biomedical applications of exosomes, Science, 367, eaau6977, 10.1126/science.aau6977 · DOI · Paper page
  69. Zhao, 2015, The role of exosomes and “exosomal shuttle microRNA” in tumorigenesis and drug resistance, Cancer Lett., 356, 339, 10.1016/j.canlet.2014.10.027 · DOI
  70. Casajuana Ester, M., and Day, R.M. (2023). Production and Utility of Extracellular Vesicles with 3D Culture Methods. Pharmaceutics, 15. · DOI
  71. Yousafzai, 2018, Exosome mediated multidrug resistance in cancer, Am. J. Cancer Res., 8, 2210
  72. Zhang, 2020, In vitro and in vivo biocompatibility and inflammation response of methacrylated and maleated hyaluronic acid for wound healing, RSC Adv., 10, 32183, 10.1039/D0RA06025A · DOI
  73. Gurung, 2021, The exosome journey: From biogenesis to uptake and intracellular signalling, Cell Commun. Signal, 19, 47, 10.1186/s12964-021-00730-1 · DOI
  74. Peng, 2016, Regulation of epithelial-mesenchymal transition through microRNAs: Clinical and biological significance of microRNAs in breast cancer, Tumour Biol., 37, 14463, 10.1007/s13277-016-5334-1 · DOI
  75. Feng, 2019, Exosomes promote pre-metastatic niche formation in ovarian cancer, Mol. Cancer, 18, 124, 10.1186/s12943-019-1049-4 · DOI
  76. Xu, 2016, Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling, Biochem. Biophys. Res. Commun., 479, 893, 10.1016/j.bbrc.2016.09.087 · DOI
  77. Chen, W.X., Liu, X.M., Lv, M.M., Chen, L., Zhao, J.H., Zhong, S.L., Ji, M.H., Hu, Q., Luo, Z., and Wu, J.Z. (2014). Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS ONE, 9. · DOI
  78. Enriquez, V.A., Cleys, E.R., Da Silveira, J.C., Spillman, M.A., Winger, Q.A., and Bouma, G.J. (2015). High LIN28A Expressing Ovarian Cancer Cells Secrete Exosomes That Induce Invasion and Migration in HEK293 Cells. Biomed. Res. Int., 2015. · DOI
  79. Zhao, 2021, Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1, Aging, 13, 18498, 10.18632/aging.203298 · DOI
  80. Liu, 2021, Carcinoma associated fibroblasts small extracellular vesicles with low miR-7641 promotes breast cancer stemness and glycolysis by HIF-1α, Cell Death Discov., 7, 176, 10.1038/s41420-021-00524-x · DOI
  81. Hegmans, 2004, Proteomic analysis of exosomes secreted by human mesothelioma cells, Am. J. Pathol., 164, 1807, 10.1016/S0002-9440(10)63739-X · DOI
  82. Futter, 2007, Annexins and endocytosis, Traffic, 8, 951, 10.1111/j.1600-0854.2007.00590.x · DOI
  83. Westergard, 2016, Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD, Cell Rep., 17, 645, 10.1016/j.celrep.2016.09.032 · DOI
  84. Yamada, 2007, Modeling tissue morphogenesis and cancer in 3D, Cell, 130, 601, 10.1016/j.cell.2007.08.006 · DOI · Paper page
  85. Hirschhaeuser, 2010, Multicellular tumor spheroids: An underestimated tool is catching up again, J. Biotechnol., 148, 3, 10.1016/j.jbiotec.2010.01.012 · DOI · Paper page
  86. Gao, 2020, Exosomes from 3D culture of marrow stem cells enhances endothelial cell proliferation, migration, and angiogenesis via activation of the HMGB1/AKT pathway, Stem Cell Res., 50, 102122, 10.1016/j.scr.2020.102122 · DOI
  87. Wahlgren, 2012, Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytes, Nucleic Acids Res., 40, e130, 10.1093/nar/gks463 · DOI
  88. Seow, 2011, Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes, Nat. Biotechnol., 29, 341, 10.1038/nbt.1807 · DOI · Paper page
  89. Zhu, 2012, Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo, Cancer Lett., 315, 28, 10.1016/j.canlet.2011.10.002 · DOI · Paper page
  90. Bruno, 2013, Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth, Stem Cells Dev., 22, 758, 10.1089/scd.2012.0304 · DOI
  91. Breakefield, 2013, Extracellular vesicles: Biology and emerging therapeutic opportunities, Nat. Rev. Drug Discov., 12, 347, 10.1038/nrd3978 · DOI · Paper page
  92. Boya, 2020, Circulating Tumor Cell Enrichment Technologies, Recent. Results Cancer Res., 215, 25, 10.1007/978-3-030-26439-0_2 · DOI
  93. Korde, 2021, Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline, J. Clin. Oncol., 39, 1485, 10.1200/JCO.20.03399 · DOI
  94. Yang, 2015, Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio, Pharm. Res., 32, 2003, 10.1007/s11095-014-1593-y · DOI
  95. Yu, 2017, Role of tumor microenvironment in triple-negative breast cancer and its prognostic significance, Chin. J. Cancer Res., 29, 237, 10.21147/j.issn.1000-9604.2017.03.10 · DOI
  96. Deepak, 2020, Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer, Pharmacol. Res., 153, 104683, 10.1016/j.phrs.2020.104683 · DOI
  97. Tsai, 2013, Epithelial-mesenchymal plasticity in carcinoma metastasis, Genes. Dev., 27, 2192, 10.1101/gad.225334.113 · DOI
  98. da Costa, V.R., Araldi, R.P., Vigerelli, H., D’Ámelio, F., Mendes, T.B., Gonzaga, V., Policíquio, B., Colozza-Gama, G.A., Valverde, C.W., and Kerkis, I. (2021). Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications. Cells, 10. · DOI
  99. Porcacchia, 2017, The Roles of ROS in Cancer Heterogeneity and Therapy, Oxid. Med. Cell Longev., 2017, 2467940, 10.1155/2017/2467940 · DOI
  100. Araldi, R.P., de Melo, T.C., Levy, D., de Souza, D.M., Maurício, B., Colozza-Gama, G.A., Bydlowski, S.P., Peng, H., Rauscher, F.J., and Cerutti, J.M. (2020). LIMD2 Regulates Key Steps of Metastasis Cascade in Papillary Thyroid Cancer Cells via MAPK Crosstalk. Cells, 9. · DOI
  101. Araldi, 2016, Genetics and metabolic deregulation following cancer initiation: A world to explore, Biomed. Pharmacother., 82, 449, 10.1016/j.biopha.2016.05.031 · DOI
  102. Mittal, 2018, Epithelial Mesenchymal Transition in Tumor Metastasis, Annu. Rev. Pathol., 13, 395, 10.1146/annurev-pathol-020117-043854 · DOI · Paper page
  103. Roy, 2014, Candidate prognostic markers in breast cancer: Focus on extracellular proteases and their inhibitors, Breast Cancer Targets Ther., 6, 81
  104. Chong, 2012, Matricellular proteins: A sticky affair with cancers, J. Oncol., 2012, 351089, 10.1155/2012/351089 · DOI
  105. Lu, 2012, The extracellular matrix: A dynamic niche in cancer progression, J. Cell Biol., 196, 395, 10.1083/jcb.201102147 · DOI · Paper page
  106. Filipazzi, 2012, Recent advances on the role of tumor exosomes in immunosuppression and disease progression, Semin. Cancer Biol., 22, 342, 10.1016/j.semcancer.2012.02.005 · DOI
  107. Galassi, C., Musella, M., Manduca, N., Maccafeo, E., and Sistigu, A. (2021). The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure. Cells, 10. · DOI
  108. Domenis, R., Cesselli, D., Toffoletto, B., Bourkoula, E., Caponnetto, F., Manini, I., Beltrami, A.P., Ius, T., Skrap, M., and Di Loreto, C. (2017). Systemic T Cells Immunosuppression of Glioma Stem Cell-Derived Exosomes Is Mediated by Monocytic Myeloid-Derived Suppressor Cells. PLoS ONE, 12. · DOI
  109. Whiteside, 2013, Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes), Biochem. Soc. Trans., 41, 245, 10.1042/BST20120265 · DOI
  110. Skardal, 2016, Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling, Drug Discov. Today, 21, 1399, 10.1016/j.drudis.2016.07.003 · DOI · Paper page
  111. Hardin, 2018, Thyroid cancer stem-like cell exosomes: Regulation of EMT via transfer of lncRNAs, Lab. Investig., 98, 1133, 10.1038/s41374-018-0065-0 · DOI
  112. Yan, 2014, Characterization of cancer stem-like cells derived from mouse induced pluripotent stem cells transformed by tumor-derived extracellular vesicles, J. Cancer, 5, 572, 10.7150/jca.8865 · DOI
  113. Goetz, 2011, Biomechanical remodeling of the microenvironment by stromal caveolin-1 favors tumor invasion and metastasis, Cell, 146, 148, 10.1016/j.cell.2011.05.040 · DOI · Paper page
  114. Sung, 2021, Global Cancer Statistics 2020, GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J. Clin., 71, 209, 10.3322/caac.21660 · DOI · Paper page
  115. Dou, 2020, Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway, Front. Immunol., 11, 2026, 10.3389/fimmu.2020.02026 · DOI
  116. Sopik, 2021, International variation in breast cancer incidence and mortality in young women, Breast Cancer Res. Treat., 186, 497, 10.1007/s10549-020-06003-8 · DOI
  117. Gajewski, 2006, Immune resistance orchestrated by the tumor microenvironment, Immunol. Rev., 213, 131, 10.1111/j.1600-065X.2006.00442.x · DOI · Paper page
  118. Yousafzai, 2021, Recent advances of SIRT1 and implications in chemotherapeutics resistance in cancer, Am. J. Cancer Res., 11, 5233
  119. Ullah, 2019, Klotho Deficiency Accelerates Stem Cells Aging by Impairing Telomerase Activity, J. Gerontol. A Biol. Sci. Med. Sci., 74, 1396, 10.1093/gerona/gly261 · DOI · Paper page
  120. Denzer, 2000, Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface, J. Immunol., 165, 1259, 10.4049/jimmunol.165.3.1259 · DOI
  121. Morelli, 2004, Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells, Blood, 104, 3257, 10.1182/blood-2004-03-0824 · DOI
  122. Czernek, 2017, Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression, Arch. Immunol. Ther. Exp., 65, 311, 10.1007/s00005-016-0453-3 · DOI
  123. Ullah, 2018, Stem cells and anti-aging genes: Double-edged sword-do the same job of life extension, Stem Cell Res. Ther., 9, 3, 10.1186/s13287-017-0746-4 · DOI
  124. Ullah, M., Stich, S., Häupl, T., Eucker, J., Sittinger, M., and Ringe, J. (2013). Reverse differentiation as a gene filtering tool in genome expression profiling of adipogenesis for fat marker gene selection and their analysis. PLoS ONE, 8. · DOI
  125. Harper, 2014, Regulation of the anti-tumour immune response by cancer-associated fibroblasts, Semin. Cancer Biol., 25, 69, 10.1016/j.semcancer.2013.12.005 · DOI
  126. Bartosh, 2016, Cancer cells enter dormancy after cannibalizing mesenchymal stem/stromal cells (MSCs), Proc. Natl. Acad. Sci. USA, 113, E6447, 10.1073/pnas.1612290113 · DOI
  127. Baghban, 2023, The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review, Front. Pharmacol., 14, 1082066, 10.3389/fphar.2023.1082066 · DOI
  128. Yang, 2012, Plasma-derived MHC class II+ exosomes from tumor-bearing mice suppress tumor antigen-specific immune responses, Eur. J. Immunol., 42, 1778, 10.1002/eji.201141978 · DOI
  129. Wieckowski, 2009, Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes, J. Immunol., 183, 3720, 10.4049/jimmunol.0900970 · DOI
  130. Hong, C.S., Muller, L., Boyiadzis, M., and Whiteside, T.L. (2014). Isolation and characterization of CD34+ blast-derived exosomes in acute myeloid leukemia. PLoS ONE, 9. · DOI
  131. Hart, 2015, Challenges in the management of advanced, ER-positive, HER2-negative breast cancer, Nat. Rev. Clin. Oncol., 12, 541, 10.1038/nrclinonc.2015.99 · DOI
  132. Kumar, 2021, FOXA1 is a determinant of drug resistance in breast cancer cells, Breast Cancer Res. Treat., 186, 317, 10.1007/s10549-020-06068-5 · DOI
  133. Ebrahimi, 2022, The potential application of organoids in breast cancer research and treatment, Hum. Genet., 141, 193, 10.1007/s00439-021-02390-0 · DOI
  134. Gao, 2021, Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling, Cell Death Dis., 12, 414, 10.1038/s41419-021-03692-x · DOI
  135. Qin, 2017, Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner, Int. J. Nanomed., 12, 3721, 10.2147/IJN.S131516 · DOI
  136. Fu, 2023, Retraction Note: Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway, J. Exp. Clin. Cancer Res., 42, 174, 10.1186/s13046-023-02761-7 · DOI
  137. Yu, 2016, Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222, Tumour Biol., 37, 3227, 10.1007/s13277-015-4161-0 · DOI
  138. Zhang, S., Zhang, Y., Qu, J., Che, X., Fan, Y., Hou, K., Guo, T., Deng, G., Song, N., and Li, C. (2017). Exosomes promote cetuximab resistance via the PTEN/Akt pathway in colon cancer cells. Braz. J. Med. Biol. Res., 51. · DOI
  139. Yousafzai, 2019, SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer, Cell Death Dis., 10, 363, 10.1038/s41419-019-1592-3 · DOI
  140. Kharaziha, 2015, Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel, Oncotarget, 6, 21740, 10.18632/oncotarget.3226 · DOI
  141. Schinkel, 2006, The function of breast cancer resistance protein in epithelial barriers, stem cells and milk secretion of drugs and xenotoxins, Trends Pharmacol. Sci., 27, 10, 10.1016/j.tips.2005.11.007 · DOI
  142. Melo, 2015, Glypican-1 identifies cancer exosomes and detects early pancreatic cancer, Nature, 523, 177, 10.1038/nature14581 · DOI · Paper page
  143. Han, 2017, CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer, Oncotarget, 8, 103557, 10.18632/oncotarget.21581 · DOI
  144. Yuwen, 2017, MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer, Eur. Rev. Med. Pharmacol. Sci., 21, 2650
  145. Yang, 2017, Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer, Gene, 623, 5, 10.1016/j.gene.2017.04.031 · DOI
  146. Sogawa, C., Eguchi, T., Tran, M.T., Ishige, M., Trin, K., Okusha, Y., Taha, E.A., Lu, Y., Kawai, H., and Sogawa, N. (2020). Antiparkinson Drug Benztropine Suppresses Tumor Growth, Circulating Tumor Cells, and Metastasis by Acting on SLC6A3/DAT and Reducing STAT3. Cancers, 12. · DOI
  147. Sogawa, 2019, A Reporter System Evaluates Tumorigenesis, Metastasis, β-catenin/MMP Regulation, and Druggability, Tissue Eng. Part A, 25, 1413, 10.1089/ten.tea.2018.0348 · DOI
  148. Walsh, 2014, Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer, Cancer Res., 74, 5184, 10.1158/0008-5472.CAN-14-0663 · DOI
  149. Liu, 2017, Exosomes Secreted from Human-Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Prevent Osteonecrosis of the Femoral Head by Promoting Angiogenesis, Int. J. Biol. Sci., 13, 232, 10.7150/ijbs.16951 · DOI
  150. Kinnaird, 2004, Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms, Circ. Res., 94, 678, 10.1161/01.RES.0000118601.37875.AC · DOI · Paper page
  151. Haraszti, 2018, Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular Vesicles, Mol. Ther., 26, 1973, 10.1016/j.ymthe.2018.05.024 · DOI · Paper page
  152. Dong, 2020, Exosomes and breast cancer drug resistance, Cell Death Dis., 11, 987, 10.1038/s41419-020-03189-z · DOI
  153. Michel, 2020, Immune Checkpoint Blockade in Patients with Triple-Negative Breast Cancer, Target. Oncol., 15, 415, 10.1007/s11523-020-00730-0 · DOI
  154. Bliss, 2016, Mesenchymal Stem Cell-Derived Exosomes Stimulate Cycling Quiescence and Early Breast Cancer Dormancy in Bone Marrow, Cancer Res., 76, 5832, 10.1158/0008-5472.CAN-16-1092 · DOI
  155. Bovy, 2015, Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer, Oncotarget, 6, 10253, 10.18632/oncotarget.3520 · DOI · Paper page
  156. O’Neill, C.P., Gilligan, K.E., and Dwyer, R.M. (2019). Role of Extracellular Vesicles (EVs) in Cell Stress Response and Resistance to Cancer Therapy. Cancers, 11. · DOI

Cited by

Sorted by citations

See all 20

Metadata

Authors
Yousafzai, N. A., El Khalki, L., Wang, W., Szpendyk, J., & Sossey-Alaoui, K.
Venue
Cancers
Publisher
MDPI AG
Published
2024-02-22
Volume
16
Issue
5
Pages
883
ISSN
2072-6694
DOI
10.3390/cancers16050883
PMC
PMC10931050
Cited by
20
References
13
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (vor)
Funders
  • National Institutes of Health of the United States of America (R01CA226921, R01CA272621)
  • METAvivor Translational Research Award (R01CA226921, R01CA272621)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review